MiRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 10, 2012, Pages 1641-1650

  Zhang, Yong Kui ^a   Zhu, Wang Yu ^a   He, Jian Ying ^a   Chen, Dong Dong ^a   Huang, Yan Yan ^a   Le, Han Bo ^a   Liu, Xiao Guang ^a  

^a Zhoushan Hospital of Zhejiang Province   (China)

Author keywords

Cigarette smoking; Expression; Histological subtypes; MicroRNAs; Non small cell lung carcinoma; Quantitative RT PCR

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 125A 5P; MICRORNA 205; MICRORNA 221; MICRORNA 93; MICRORNA LET 7E; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SMOKING; TUMOR VOLUME;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; PROGNOSIS; SMOKING;

EID: 84866732589     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1240-0     Document Type: Article

References (29)

1. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH (2010) Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16(2):610-619
2. Boffetta P, Jayaprakash V, Yang P et al (2011) Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the international lung cancer consortium (ILCCO). Cancer Causes Control 22:1-7
3. Frost G, Darnton A, Harding AH (2011) The effect of smoking on the risk of lung cancer mortality for asbestos workers in Great Britain. Ann Occup Hyg 55(3):239-241
4. Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10(5):593-601
5. Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91(14):1194-1210
6. Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, Papotti M (2008) The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 3(12):1468-1481
7. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23(3):806-812
8. Johnson CD, Esquela-Kerscher A, Stefani G et al (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67(16):7713-7722
9. Jorda M, Gomez-Fernandez C, Garcia M et al (2009) P63 differentiates subtypes of non-small cell carcinomas of lung in cytologic samples. Cancer Cytopathol 117(1):46-50
10. Landi MT, Zhao Y, Rotunno M et al (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 16(2):430-441
11. Lebanony D, Benjamin H, Gilad S et al (2009) Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27(12):2030-2037
12. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21(9):1025-1030
13. Li Y, VandenBoom TG, Kong D et al (2009) Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69(16):6704-6712
14. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta] CT method. Methods 25(4):402-408
15. Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834-838
16. Majid S, Dar AA, Saini S et al (2010) MicroRNA-205 directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116(24):5637-5649
17. Medina PP, Slack FJ (2008) MicroRNAs and cancer: an overview. Cell Cycle 7:2485-2492
18. Miller YE (2005) Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 33(3):216-223
19. Ragusa M, Majorana A, Statello L et al (2010) Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment. Mol Cancer Ther 9(12):3396-3403
20. Raponi M, Dossey L, Jatkoe T et al (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69(14):5583-5776
21. Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetr-exed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26(21):3543-3551
22. Takamizawa J, Konishi H, Yanagisawa K et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64(11):3753-3756
23. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20(16):2202-2207
24. Van Pottelberge GR, Mestdagh P, Bracke KR et al (2010) MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183:898-906
25. Vescovo VD, Cantaloni C, Cucino A et al (2011) MiR-205 expression levels in non-small cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol 35(2):268-275
26. Wang B, Howel P, Bruheim S et al (2011) Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One 6(2):e17167
27. Xing L, Todd NW, Yu L, Fang HB, Jiang F (2010) Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 23(8):1157-1164
28. Yanaihara N, Caplen N, Bowman E et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189-198
29. Yu SL, Chen HY, Chang GC et al (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13(1):48-57